Tandem Diabetes Care Inc (TNDM)
32.83
+0.92
(+2.88%)
USD |
NASDAQ |
Nov 04, 16:00
32.50
-0.33
(-1.01%)
After-Hours: 20:00
Tandem Diabetes Care Net Income (Quarterly): -30.81M for June 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -30.81M |
| March 31, 2024 | -42.72M |
| December 31, 2023 | -30.00M |
| September 30, 2023 | -32.96M |
| June 30, 2023 | -35.78M |
| March 31, 2023 | -123.87M |
| December 31, 2022 | -15.85M |
| September 30, 2022 | -48.97M |
| June 30, 2022 | -15.06M |
| March 31, 2022 | -14.72M |
| December 31, 2021 | 10.81M |
| September 30, 2021 | 5.794M |
| June 30, 2021 | 4.008M |
| March 31, 2021 | -5.044M |
| December 31, 2020 | 17.00M |
| September 30, 2020 | -9.408M |
| June 30, 2020 | -27.11M |
| March 31, 2020 | -14.87M |
| December 31, 2019 | 2.652M |
| September 30, 2019 | -2.901M |
| June 30, 2019 | -1.512M |
| March 31, 2019 | -22.99M |
| December 31, 2018 | 3.688M |
| September 30, 2018 | -34.24M |
| Date | Value |
|---|---|
| June 30, 2018 | -59.36M |
| March 31, 2018 | -32.69M |
| December 31, 2017 | -11.41M |
| September 30, 2017 | -16.04M |
| June 30, 2017 | -21.80M |
| March 31, 2017 | -23.79M |
| December 31, 2016 | -14.82M |
| September 30, 2016 | -29.81M |
| June 30, 2016 | -18.32M |
| March 31, 2016 | -20.48M |
| December 31, 2015 | -12.09M |
| September 30, 2015 | -19.58M |
| June 30, 2015 | -19.53M |
| March 31, 2015 | -21.21M |
| December 31, 2014 | -18.47M |
| September 30, 2014 | -19.90M |
| June 30, 2014 | -19.20M |
| March 31, 2014 | -21.96M |
| December 31, 2013 | -23.61M |
| September 30, 2013 | -13.06M |
| June 30, 2013 | -15.30M |
| March 31, 2013 | -11.16M |
| December 31, 2012 | -8.554M |
| September 30, 2012 | -7.513M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-123.87M
Minimum
Mar 2023
17.00M
Maximum
Dec 2020
-21.42M
Average
-15.06M
Median
Jun 2022
Net Income (Quarterly) Benchmarks
| Boston Scientific Corp | 468.00M |
| RxSight Inc | -6.079M |
| Perspective Therapeutics Inc | -11.70M |
| Xtant Medical Holdings Inc | -3.861M |
| Catheter Precision Inc | -4.22M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 221.91M |
| Total Expenses (Quarterly) | 252.68M |
| EPS Diluted (Quarterly) | -0.47 |
| Enterprise Value | 1.985B |
| Gross Profit Margin (Quarterly) | 50.83% |
| Profit Margin (Quarterly) | -13.89% |
| Earnings Yield | -6.37% |
| Normalized Earnings Yield | -6.319 |